×

Formulated composition

  • US 6,559,122 B1
  • Filed: 03/30/2000
  • Issued: 05/06/2003
  • Est. Priority Date: 04/08/1999
  • Status: Expired due to Term
First Claim
Patent Images

1. A composition comprising a mixture of insulin-like growth factor-I (IGF-I) and hexameric insulin without zinc and protamine (hexameric insulin) and an excipient selected from the group consisting of arginine, lysine, glutamate, sodium dodecyl sulfate, and a combination of beta-hydroxy cyclodextrin and arginine, wherein the IGF-I and hexameric insulin remain completely solvated in the composition, and wherein the hexameric insulin and IGF-I are present in a volume:

  • volume ratio of from about 1;

    6 to 6;

    1.

View all claims
  • 1 Assignment
Timeline View
Assignment View
    ×
    ×